Cargando…

Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication

The papain-like protease (PLpro) plays a critical role in SARS-CoV-2 (SCoV-2) pathogenesis and is essential for viral replication and for allowing the virus to evade the host immune response. Inhibitors of PLpro have great therapeutic potential, however, developing them has been challenging due to P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajaj, Teena, Wehri, Eddie, Suryawanshi, Rahul K., King, Elizabeth, Pardeshi, Kundan Singh, Behrouzi, Kamyar, Khodabakhshi, Zahra, Schulze-Gahmen, Ursula, Kumar, G. Renuka, Mofrad, Mohammad R. K., Nomura, Daniel K., Ott, Melanie, Schaletzky, Julia, Murthy, Niren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2023
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259201/ https://www.ncbi.nlm.nih.gov/pubmed/37312993 http://dx.doi.org/10.1039/d3ra01915b

Ejemplares similares

Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV
por: Lokugamage, Kumari G., et al.
Publicado: (2008)

A covalent inhibitor targeting the papain-like protease from SARS-CoV-2 inhibits viral replication
por: Han, Hesong, et al.
Publicado: (2023)

SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions
por: Torrens-Fontanals, Mariona, et al.
Publicado: (2021)

Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
por: Klemm, Theresa, et al.
Publicado: (2020)

Genetically Encoded Fluorescent Sensors for SARS-CoV-2 Papain-like Protease PLpro
por: Sokolinskaya, Elena L., et al.
Publicado: (2022)

Swine coronaviruses (SCoVs) and their emerging threats to swine population, inter-species transmission, exploring the susceptibility of pigs for SARS-CoV-2 and zoonotic concerns
por: Thakor, Jigarji C., et al.
Publicado: (2022)

Identification of SARS‐CoV‐2 Papain‐like Protease (PLpro) Inhibitors Using Combined Computational Approach
por: Sencanski, Milan, et al.
Publicado: (2022)

Association between Mutations in Papain-like Protease (PLpro) of SARS-CoV-2 with COVID-19 Clinical Outcomes
por: Tan, Jinlin, et al.
Publicado: (2022)

Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity
por: Kawall, Anasha, et al.
Publicado: (2023)

Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies
por: Ali Dahhas, Mohammed, et al.
Publicado: (2023)

Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro
por: Lewis, Devin S. M., et al.
Publicado: (2022)

Inhibitors of SARS-CoV-2 PLpro
por: Calleja, Dale J., et al.
Publicado: (2022)

Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease
por: Mirza, Muhammad Usman, et al.
Publicado: (2020)

SARS-CoV-2: the many pros of targeting PLpro
por: McClain, Christopher B., et al.
Publicado: (2020)

SARS-COV-2 Coronavirus Papain-like Protease PLpro as an Antiviral Target for Inhibitors of Active Site and Protein–Protein Interactions
por: Ershov, P. V., et al.
Publicado: (2023)

Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro
por: Alaofi, Ahmed L., et al.
Publicado: (2022)

Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-docking
por: Castillo-Campos, Luis, et al.
Publicado: (2023)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro
por: Swaim, Caleb D., et al.
Publicado: (2021)

Meticulous assessment of natural compounds from NPASS database for identifying analogue of GRL0617, the only known inhibitor for SARS-CoV2 papain-like protease (PLpro) using rigorous computational workflow
por: Parmar, Paritosh, et al.
Publicado: (2021)

Identifying structural–functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation
por: Rao, Priyashi, et al.
Publicado: (2021)

SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA
por: Jack, Amanda, et al.
Publicado: (2021)

6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities
por: Swaim, Caleb D., et al.
Publicado: (2020)

High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
por: Zhao, Yao, et al.
Publicado: (2021)

Evaluating Stability and Activity of SARS-CoV-2 PLpro for High-throughput Screening of Inhibitors
por: Arya, Rimanshee, et al.
Publicado: (2021)

Phytocompounds as potential inhibitors of SARS-CoV-2 Mpro and PLpro through computational studies
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Identification and characterization of aurintricarboxylic acid as a potential inhibitor of SARS-CoV-2 PLpro
por: Arya, Rimanshee, et al.
Publicado: (2023)

Gold nanoparticle based plasmonic sensing for the detection of SARS-CoV-2 nucleocapsid proteins
por: Behrouzi, Kamyar, et al.
Publicado: (2022)

Insight on Mercapto-Coumarins: Synthesis and Reactivity
por: El-Sawy, Eslam Reda, et al.
Publicado: (2022)

SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA
por: Jack, Amanda, et al.
Publicado: (2021)

SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA
por: Jack, Amanda, et al.
Publicado: (2022)

Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
por: Narayanan, Anoop, et al.
Publicado: (2022)

The application of in silico experimental model in the assessment of ciprofloxacin and levofloxacin interaction with main SARS-CoV-2 targets: S-, E- and TMPRSS2 proteins, RNA-dependent RNA polymerase and papain-like protease (PLpro)—preliminary molecular docking analysis
por: Marciniec, Krzysztof, et al.
Publicado: (2021)

Structure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19
por: Bhati, Shipra
Publicado: (2020)

Can Papain-like Protease Inhibitors Halt SARS-CoV-2 Replication?
por: Maiti, Biplab K
Publicado: (2020)

Deubiquitinating Activity of the SARS-CoV Papain-Like Protease
por: Barretto, Naina, et al.
Publicado: (2006)

THE GERMICIDAL ACTION OF α-MERCAPTO AND α-DISULFO SOAPS
por: Eggerth, Arnold H.
Publicado: (1931)

Stimulated Emission Depletion Lithography with Mercapto-Functional Polymers
por: Buchegger, Bianca, et al.
Publicado: (2016)

Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics
por: Hossain, Mohammad Uzzal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_four8c07l1n96bl6ffsfvdlklb